HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹908 Cr | ₹851 Cr | ₹799 Cr | ₹655 Cr | ₹545 Cr |
What is the latest Appropriations of HIKAL ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹908 Cr |
| Mar2024 | ₹851 Cr |
| Mar2023 | ₹799 Cr |
| Mar2022 | ₹655 Cr |
| Mar2021 | ₹545 Cr |
How is Appropriations of HIKAL Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹908 Cr | 6.66 | |
| Mar2024 | ₹851 Cr | 6.56 | |
| Mar2023 | ₹799 Cr | 22.04 | |
| Mar2022 | ₹655 Cr | 20.03 | |
| Mar2021 | ₹545 Cr | - | |
Compare Appropriations of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹1,933.3 Cr | -7.8% | -22.5% | -58% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -7.8% |
-22.5% |
-58% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses